$ADPT Adaptive Biotechnologies Corp Insider Trading Week 52/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp in week 52/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 26,563 | |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 26,563 | |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 4,759 | 37,120 | 29,167 | |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 4,759 | 37,120 | 29,167 | |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 59.27 | 391 | 23,175 | 1,300 | 1.7 K to 1.3 K (-23.12 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 59.27 | 391 | 23,175 | 1,300 | 1.7 K to 1.3 K (-23.12 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 58.40 | 1,610 | 94,024 | 1,691 | 3.3 K to 1.7 K (-48.77 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 58.40 | 1,610 | 94,024 | 1,691 | 3.3 K to 1.7 K (-48.77 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 57.54 | 4,529 | 260,599 | 3,301 | 7.8 K to 3.3 K (-57.84 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 57.54 | 4,529 | 260,599 | 3,301 | 7.8 K to 3.3 K (-57.84 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 7,830 | 6.1 K to 7.8 K (+29.23 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 7,830 | 6.1 K to 7.8 K (+29.23 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 4,759 | 37,120 | 6,059 | 1.3 K to 6.1 K (+366.08 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 4,759 | 37,120 | 6,059 | 1.3 K to 6.1 K (+366.08 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 380,000 | |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 380,000 | |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.27 | 638 | 37,814 | 0 | 638 to 0 (-100.00 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.27 | 638 | 37,814 | 0 | 638 to 0 (-100.00 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.25 | 6,386 | 371,985 | 638 | 7 K to 638 (-90.92 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 58.25 | 6,386 | 371,985 | 638 | 7 K to 638 (-90.92 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.56 | 7,976 | 459,099 | 7,024 | 15 K to 7 K (-53.17 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 57.56 | 7,976 | 459,099 | 7,024 | 15 K to 7 K (-53.17 %) |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 31 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,520 | 5,452 | 0 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,790 | 5,541 | 16,520 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,250 | 5,363 | 33,310 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.65 | 8,869 | 529,036 | 1,778,180 | 1.8 M to 1.8 M (-0.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.20 | 7,651 | 452,939 | 1,787,049 | 1.8 M to 1.8 M (-0.43 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,520 | 5,452 | 1,794,700 | 1.8 M to 1.8 M (+0.93 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.73 | 1,700 | 103,241 | 1,778,180 | 1.8 M to 1.8 M (-0.10 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 59.42 | 6,834 | 406,076 | 1,779,880 | 1.8 M to 1.8 M (-0.38 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 58.87 | 8,256 | 486,031 | 1,786,714 | 1.8 M to 1.8 M (-0.46 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,790 | 5,541 | 1,794,970 | 1.8 M to 1.8 M (+0.94 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 63.41 | 100 | 6,341 | 1,778,180 | 1.8 M to 1.8 M (-0.01 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 62.60 | 1,500 | 93,900 | 1,778,280 | 1.8 M to 1.8 M (-0.08 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 395,000 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 61.48 | 1,108 | 68,120 | 1,779,780 | 1.8 M to 1.8 M (-0.06 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 410,000 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 60.71 | 13,542 | 822,135 | 1,780,888 | 1.8 M to 1.8 M (-0.75 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 425,000 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,250 | 5,363 | 1,794,430 | 1.8 M to 1.8 M (+0.91 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.12 | 1,700 | 102,204 | 0 | 1.7 K to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 395,000 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.55 | 13,300 | 792,015 | 1,700 | 15 K to 1.7 K (-88.67 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 410,000 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 425,000 | |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.32 | 1,853 | 113,626 | 0 | 1.9 K to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.12 | 1,700 | 102,204 | 0 | 1.7 K to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.72 | 6,922 | 420,304 | 1,853 | 8.8 K to 1.9 K (-78.88 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.55 | 13,300 | 792,015 | 1,700 | 15 K to 1.7 K (-88.67 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.48 | 6,225 | 370,263 | 8,775 | 15 K to 8.8 K (-41.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 61.32 | 1,853 | 113,626 | 0 | 1.9 K to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.95 | 200 | 12,790 | 0 | 200 to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.72 | 6,922 | 420,304 | 1,853 | 8.8 K to 1.9 K (-78.88 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.33 | 2,258 | 142,999 | 200 | 2.5 K to 200 (-91.86 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 59.48 | 6,225 | 370,263 | 8,775 | 15 K to 8.8 K (-41.50 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.04 | 3,735 | 231,719 | 2,458 | 6.2 K to 2.5 K (-60.31 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.89 | 8,807 | 536,258 | 6,193 | 15 K to 6.2 K (-58.71 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.95 | 200 | 12,790 | 0 | 200 to 0 (-100.00 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.33 | 2,258 | 142,999 | 200 | 2.5 K to 200 (-91.86 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.04 | 3,735 | 231,719 | 2,458 | 6.2 K to 2.5 K (-60.31 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 60.89 | 8,807 | 536,258 | 6,193 | 15 K to 6.2 K (-58.71 %) |
| Dec 30 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 6.32 | 15,000 | 94,800 | 440,000 | |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 65.39 | 378 | 24,717 | 0 | 378 to 0 (-100.00 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 64.29 | 3,741 | 240,509 | 378 | 4.1 K to 378 (-90.82 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 63.71 | 7,394 | 471,072 | 4,119 | 11.5 K to 4.1 K (-64.22 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 62.15 | 3,487 | 216,717 | 11,513 | 15 K to 11.5 K (-23.25 %) |
| Dec 28 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 6.32 | 15,000 | 94,800 | 15,000 | 0 to 15 K |